Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2018; 8(11): 116-122


Two-phase extraction, characterization, and biological evaluation of chitin and chitosan from Rhizopus oryzae

Dhanashree B. Gachhi, Basavaraj S. Hungund.




Abstract

Chitin is a polysaccharide based on the monomers of N-acetyl-glucosamine and chitosan is a deacetylated form of it. Our study is emphasized on two phase extraction of chitin and chitosan from fungus Rhizopus oryzae (NCIM 877) belonging to zygomycota. Optimization studies such as utilization of carbon source, pH and biomass were performed and maximum yield of chitosan (0.288 g/L) was obtained after nine days of incubation. Characterization studies of chitin and chitosan was performed using FTIR and XRD methods. Studies on degree of deacetylation (DD), molecular weight (MW) and viscosity (cP) for chitin and chitosan were found to be superior in comparison to standard. Antibacterial activity of chitosan was evaluated against test organisms Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Salmonella typhi. Chitosan demonstrated higher antibacterial activity against gram positive bacteria as compared to gram negative ones. The extracted chitosan demonstrated antioxidant activity between 60-80% as evaluated by DPPH scavenging studies.

Key words: Chitin Chitosan FTIR XRD antibacterial activity antioxidant activity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.